Granules India Limited (NSE:GRANULES)
India · Delayed Price · Currency is INR 652.65
+20.25 (3.20%)
Apr 15, 2026, 3:30 PM IST
Granules India Market Cap
Granules India has a market cap or net worth of 161.59 billion as of April 15, 2026. Its market cap has increased by 31.14% in one year.
Market Cap
161.59B
Enterprise Value
173.47B
Revenue
50.92B
Ranking
n/a
PE Ratio
29.62
Stock Price
652.65
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 161.59B, an increase of 98,610.01%. That is a compound annual growth rate of 34.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 161.59B | 11.25% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 309.11B |
| Gland Pharma | 286.99B |
| Wockhardt | 218.36B |
| Piramal Pharma | 194.49B |
| NATCO Pharma | 192.95B |
| Eris Lifesciences | 192.59B |
| Alembic Pharmaceuticals | 142.35B |
| Cohance Lifesciences | 137.19B |